Australia will add tacrolimus 0.1% ointment (Zematop) to the PBS, giving more than 143,000 people with moderate-to-severe atopic …
NICE is evaluating lebrikizumab for treating moderate-to-severe atopic dermatitis in children and young people, assessing its clinical and …